首页 | 本学科首页   官方微博 | 高级检索  
检索        

大剂量维生素C对肝硬化患者脂质过氧化损伤的保护作用
引用本文:张晓岚,姚希贤,刘永春,秦玉彩,萎慧卿.大剂量维生素C对肝硬化患者脂质过氧化损伤的保护作用[J].临床消化病杂志,2001,13(1):3-5.
作者姓名:张晓岚  姚希贤  刘永春  秦玉彩  萎慧卿
作者单位:河北医科大学第二医院,
摘    要:目的 :观察大剂量维生素C(Vit .C)对肝硬化患者脂质过氧化损伤的保护作用。方法 :将 5 8例肝硬化患者随机分为Vit .C治疗组与对照组。应用Vit .C 10 g稀释于 5 %葡萄糖 30 0~ 5 0 0ml中静脉滴注 ,每日 1次 ,连用 14天。观察治疗前后ALT、胆红素 (Bil)、血清Vit.C、丙二醛 (MDA)、超氧化物歧化酶 (SOD)、谷胱甘肽过氧化物酶 (GSH Px)水平的变化。结果 :肝硬化组血清Vit .C、SOD水平、SOD/MDA比值显著低于正常对照组 (P <0 .0 5 ) ;而MDA显著高于正常对照组 (P <0 .0 1)。应用Vit.C治疗后ALT ( 61.19± 5 3.2 8uvs 30 .95± 2 5 .33u ,P <0 .0 1)和Bil( 46.81± 41.96μmol/Lvs 36.42± 5 0 .33μmol/L ,P <0 .0 5 )明显降低 ;GSH Px、SOD/MDA比值显著性升高 ,P <0 .0 5。而且ALT( 30 .95± 2 5 .33uvs ,42 .2 0± 34 .89u ,P <0 .0 5 )和Bil( 36.42± 5 0 .33μmol/Lvs 47.89± 5 6.2 0 μmol/L ,P <0 .0 5 )明显低于对照组 :GSH Px、SOD/MDA比值显著高于 (MDA显著性低于 )对照组。结论 :氧自由基所引发的脂质过氧化作用可能是肝硬化肝损害发病机制中的重要因素之一 ,应用大剂量Vit .C( 10g/d)疗法确有降酶、退黄、改善肝功能的作用 ,其作用机制与清除OFR、抑制LP有关。

关 键 词:肝硬化  维生素C  丙二醛  超氧化物歧化酶  谷胱甘肽过氧化物酶  治疗
修稿时间:2000年7月15日

The Effect of High-dose Vitamin C on Lipid Peroxidization Injury in Patients with Hepatic Cirrhosis
Zhang Xiao lan,Yao Xi xian,Liu Yong chun,et al.The Effect of High-dose Vitamin C on Lipid Peroxidization Injury in Patients with Hepatic Cirrhosis[J].Chinese Journal of Clinical Gastroenterology,2001,13(1):3-5.
Authors:Zhang Xiao lan  Yao Xi xian  Liu Yong chun  
Institution:Zhang Xiao lan,Yao Xi xian,Liu Yong chun,et al Department of Gastroenterology,The Second Hospital of Hebei Medical University
Abstract:To observe the effects of highdose Vit. C on hepatic function and lipid peroxidization injury in cirrhotic patients. Methods: In the Vit. C-treated group, Vit. C(10 g/day) was given intravenously. The sennn Vit. C levels were measured in 58 patients with cirrhosis and 20 normal controls by high performance liquid chromatography (HPLC). The levels of malondialdehyde (MDA), superoxide dismutase (SOD) and glutathione peroxidase were measured before and after treatment with Vit. C and without Vit. C by chemocolorimetry. Results: ALT and Bil were significantly decreased respectively (ALT:61. 19 ± 53.28 u vs 30.95 ± 25.33 u, P < 0.01; Bil:46.80 ± 41.96 μmol/L vs 36.42 ± 50.33μmol/L, P < 0. 05) after treatment with Vit. C. In control group ALT was significantly decreased (42.22 ± 34.89 u vs 59. 63 ± 44.30 u, P < 0.05), but Bil was unchanged after treatment. When compared with control group, both ALT and Bil were all lower after treatment with Vit. C (P <0.05). SOD/MDA ratio and GSH-Px were significantly lower than that of normal respectively (P <0.01, P <0105). After treatment with Vit. C the SOD/MDA ratio and GSH-Px levels were significantly increased than that of control group. And MDA were significantly lower than that of control group. Conclusions: Intravenous infusion of a large dose of Vit. C as a protecting liver function drug plays an active role in patients with cirrhosis, and the effects of Vit. C can be attribute to scavenging radical and suppressing the peroxidaive reactions.
Keywords:Liver cirrhosis  Vitamine C  Malondialdehyde(MDA)  Superoxide dismutase (SOD)  Glutathione peroxidase(GSH  Px)  Randomized control test (RCT)  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号